International Journal of Legal Medicine

, Volume 122, Issue 2, pp 115–121 | Cite as

Frequency of different anti-depressants associated with suicides and drug deaths

  • Gustav Drasch
  • Felicitas Dahlmann
  • Ludwig von Meyer
  • Gabriele Roider
  • Wolfgang Eisenmenger
Original Article


From each case of suicide and drug-related death autopsied in the Institute of Forensic Medicine, Munich during the years 2001–2005, a toxicological investigation on anti-depressants (AD) was performed. In 180 suicides and 72 narcotic drug death cases, ADs were detected: 4 different classic tricyclic anti-depressants (TCAs), 6 other non-selective monoamine re-uptake inhibitors (NSMRIs), 5 selective serotonin re-uptake inhibitors (SSRIs) and 3 other ADs. The suicides were grouped further according to the type of suicide (violent or non-violent). The prescription frequency of the ADs in Germany, expressed as the defined daily dosages (DDDs), during the investigated years served for comparison. There were serious differences in the frequency of different ADs regarding to the manner of suicide. In cases associated with doxepin and trimipramine, non-violent suicides were distinctly over-represented, as in cases in which the drug itself was responsible for the death as in cases of non-violent suicides in other manners. In contrast, in cases with citalopram or opipramol, violent forms of suicides were significantly over-represented. For amitriptyline, the ratio was approximately balanced. For the remainder of the ADs, the case numbers were too low for a valid evaluation. The different frequency distributions of the ADs, associated with violent and non-violent suicides may be explained by their different pharmacological active profiles and the different lethality of overdoses of the different ADs. There was no indication at all for a special suicidal problem of SSRIs in juveniles. Amongst 1,127 suicides within 5 years, in an area with approximately 5 million people, the youngest suicide victim with SSRIs was 28 years old. In drug death cases, citalopram was obviously over-represented.


Anti-depressants Suicide Drug-related death Frequency Autopsy Juveniles 


  1. 1.
    Maris RW (2002) Suicide. Lancet 360:319–326PubMedCrossRefGoogle Scholar
  2. 2.
    Möller HJ (2006) Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review. Eur Arch Psychiatry Clin Neurosci 256:476–496PubMedCrossRefGoogle Scholar
  3. 3.
    Ray WA, Meredith S, Thapa PB, Hall K, Murray KT (2004) Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 75:234–241PubMedCrossRefGoogle Scholar
  4. 4.
    WHO Collaboration Centre for Drug Statistics Methodology (2006) The DDD—definition and principles.
  5. 5.
    Lohse MJ, Lorenzen A, Müller-Oerlinghausen B (2002) In: Schwabe U, Paffrath D (eds) Arzneimittelverordnungs—report 2002. Springer, BerlinGoogle Scholar
  6. 6.
    Lohse MJ, Lorenzen A, Müller-Oerlinghausen B (2003) In: Schwabe U, Paffrath D (eds) Arzneimittelverordnungs—report 2003. Springer, BerlinGoogle Scholar
  7. 7.
    Lohse MJ, Lorenzen A, Müller-Oerlinghausen B (2004) In: Schwabe U, Paffrath D (eds) Arzneimittelverordnungs—report 2004. Springer, BerlinGoogle Scholar
  8. 8.
    Lohse MJ, Lorenzen A, Müller-Oerlinghausen B (2005) In: Schwabe U, Paffrath D (eds) Arzneimittelverordnungs—report 2005. Springer, BerlinGoogle Scholar
  9. 9.
    Lohse MJ, Lorenzen A, Müller-Oerlinghausen B (2006) In: Schwabe U, Paffrath D (eds) Arzneimittelverordnungs—report 2006. Springer, BerlinGoogle Scholar
  10. 10.
    Whyte IM, Dawson AH, Buckley NA (2003) Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 96:369–374PubMedCrossRefGoogle Scholar
  11. 11.
    Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2000) Suicide by antidepressant intoxication identified at autopsy in Vienna between 1991 and 1997: the favourable consequences of the increasing use of SSRIs. Eur Neuropsychopharmacol 10:133–142PubMedCrossRefGoogle Scholar
  12. 12.
    Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN (2004) Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 42:67–71PubMedCrossRefGoogle Scholar
  13. 13.
    Cipriani A, Barbui C, Geddes JR (2005) Suicide, depression, and antidepressants. BMJ 330:373–374PubMedCrossRefGoogle Scholar
  14. 14.
    Licinio J, Wong ML (2005) Depression, antidepressants and suicidality: a critical appraisal. Nat Rev Drug Discov 4:165–171PubMedCrossRefGoogle Scholar
  15. 15.
    Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL (2004) Efficacy and safety of antidepressants for children and adolescents. BMJ 328:879–883PubMedCrossRefGoogle Scholar
  16. 16.
    Healy D (2003) Lines of evidence on the risks of suicides with selective serotonin reuptake inhibitors. Psychother Psychosom 72:71–79PubMedCrossRefGoogle Scholar
  17. 17.
    Whittington CJ, Kendall T, Fonagy P, Cottrell D, Colgrove A, Boddington E (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341–1345PubMedCrossRefGoogle Scholar
  18. 18.
    Jick H, Kaye JA, Jick SS (2004) Antidepressants and the risk of suicidal behaviors. JAMA 292:338–343PubMedCrossRefGoogle Scholar
  19. 19.
    Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Herbert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ 330:396–402PubMedCrossRefGoogle Scholar
  20. 20.
    Juurlink DN, Mamdani MM, Kopp A, Redelmeier DA (2006) The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry 163:813–821PubMedCrossRefGoogle Scholar
  21. 21.
    Kahn A, Kahn S, Kolts R, Brown WA (2003) Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 160:790–792CrossRefGoogle Scholar
  22. 22.
    Gunnel D, Ashby D (2004) Antidepressants and suicide: what is the balance of benefit and harm? BMJ 329:34–38CrossRefGoogle Scholar
  23. 23.
    Bateman DN, Chick J, Good AM, Kelly CA, Masterton G (2004) Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose? Eur J Clin Pharmacol 60:221–224PubMedCrossRefGoogle Scholar
  24. 24.
    U.S. Food and Drug Administration (2004) FDA issues public health advisory on cautions for use of antidepressants in adults and children.
  25. 25.
    U.S. Food and Drug Administration (2004) FDA updates its review of antidepressant drugs in children.
  26. 26.
    Dubicka B, Hadley S, Roberts C (2006) Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry 189:393–398PubMedCrossRefGoogle Scholar
  27. 27.
    Lucrice Y (2005) New drugs, new problems. Aust J Forensic Sci 37:9–25Google Scholar
  28. 28.
    Koski A, Vuori E, Ojanperä I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finish postmortem data. Int J Legal Med 119:344–348PubMedCrossRefGoogle Scholar
  29. 29.
    Leon AC, Marzuk PM, Tardiff K, Bucciarelli A, Markham Piper K, Galea S (2006) Antidepressants and youth suicide in New York City, 1999–2002. J Am Acad Child Adolesc Psychiatry 45:1054–1058PubMedCrossRefGoogle Scholar
  30. 30.
    Sondergard L, Kvist K, Andersen PK, Kessing LV (2006) Do antidepressants precipitate youth suicide?: a nationwide pharmacoepidemiological study. Eur Child Adolesc Psychiatry 15:232–240PubMedCrossRefGoogle Scholar
  31. 31.
    Jonsson A, Holmgren P, Ahlner J (2004) Fatal intoxications in a Swedish forensic autopsy material during 1992–2002. Forensic Sci Int 143:53–59PubMedCrossRefGoogle Scholar
  32. 32.
    Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63:1358–1367PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Gustav Drasch
    • 1
  • Felicitas Dahlmann
    • 1
  • Ludwig von Meyer
    • 1
  • Gabriele Roider
    • 1
  • Wolfgang Eisenmenger
    • 1
  1. 1.Institute of Forensic MedicineLudwig-Maximilians-UniversityMunichGermany

Personalised recommendations